Company: BNBX
Filing Date: 2025-04-15
Form Type: DEF 14A
Source: 0001104659-25-034898
Chunk: 2

Company: BNB PLUS CORP.
Filing Date: 2025-04-15
Form: DEF 14A
Chunk 2
---
 STOCKHOLDERS Notice is hereby given that the 2025 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Applied DNA Sciences, Inc. (“ Applied DNA Sciences ” or the “ Company ”), will be held virtually at www.virtualshareholdermeeting.com/APDN2025 on Thursday, May 22, 2025 at 11:00 a.m., Eastern Time, for the following purposes: • to elect six directors, constituting the entire board of directors of the Company (the “ Board of Directors ” or “ Board ”), to serve until the Company’s next annual meeting of stockholders, or until their respective successors are duly elected and qualified; • to ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending September 30, 2025; • to grant the Board of Directors discretionary authority for 12 months to amend the Company’s certificate of incorporation, as amended (the “ Certificate of Incorporation ”), to authorize a reverse stock split of common stock, at a ratio in the range from one-for-five to one-for-fifty, with such specific ratio to be determined by the Company’s Board of Directors following the Annual Meeting (the “ Reverse Split Proposal ”); • to approve, in accordance with Nasdaq Listing Rule 5635(d), the exercisability of certain common stock purchase warrants, and the issuance of the common stock underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on October 30, 2024 (the “ Warrant Exercise Proposal ”); • to approve an amendment to the Company’s 2020 Equity Incentive Plan (the “ Plan Amendment ”) to increase the number of authorized shares of common stock reserved for issuance by 3 million shares (the “ Plan Amendment Proposal ”); • to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers (the “ Say on Pay Proposal ”); • to approve, on a non-binding advisory basis, the frequency of the stockholder vote on the compensation of the Company’s named executive officers (the “ Say on Frequency Proposal ”); and • to consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the meeting. These matters are more fully described in the accompanying Proxy Statement. Only stockholders of record at the close of business on April 3, 2025 are entitled to notice of and to vote at the Annual